Improve Medical Instruments Co (300030.SZ) Stock Price

Improve Medical Instruments Co Price

CLOSED
6.22CNY-0.44 (-6.83 %)
Market closed

Revenue has compounded at 15.4% per year over the past 18 years to 581.33 M CNY. Earnings per share have declined at 7.9% per year over the last 15 years. Improve Medical Instruments Co's net margin stands at -20.3%, down from 17.7% several years earlier. Improve Medical Instruments Co currently offers a dividend yield of about 0.64%. The stock trades about 7% above its 52-week low.

Improve Medical Instruments Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Improve Medical Instruments Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Improve Medical Instruments Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Improve Medical Instruments Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Improve Medical Instruments Co Stock Price History
DateImprove Medical Instruments Co Price
7/17/20266.22 CNY
7/16/20266.66 CNY
7/15/20266.49 CNY
7/14/20266.31 CNY
7/13/20266.06 CNY
7/10/20266.17 CNY
7/9/20265.98 CNY
7/8/20265.99 CNY
7/7/20266.09 CNY
7/6/20266.32 CNY
7/3/20266.29 CNY
7/2/20266.06 CNY
7/1/20266.14 CNY
6/30/20265.81 CNY
6/29/20265.99 CNY
6/26/20265.85 CNY
6/25/20266.06 CNY
6/24/20266.26 CNY
6/23/20266.48 CNY
6/22/20266.04 CNY
6/18/20266.22 CNY
6/17/20266.23 CNY
6/16/20266.35 CNY
6/15/20266.40 CNY
6/12/20266.46 CNY
6/11/20266.37 CNY
6/10/20266.47 CNY
6/9/20266.57 CNY
6/8/20266.53 CNY
6/5/20266.75 CNY
6/4/20266.64 CNY
6/3/20266.79 CNY
6/2/20266.87 CNY
6/1/20267.09 CNY
5/29/20266.97 CNY
5/28/20267.03 CNY
5/27/20267.03 CNY
5/26/20267.25 CNY
5/25/20267.56 CNY
5/22/20267.77 CNY
5/21/20267.68 CNY
5/20/20267.94 CNY
5/19/20268.16 CNY
5/18/20268.09 CNY
5/15/20268.15 CNY
5/14/20268.26 CNY
5/13/20268.32 CNY
5/12/20268.33 CNY
5/11/20268.56 CNY
5/8/20268.45 CNY
5/7/20268.35 CNY
5/6/20268.40 CNY
4/30/20268.32 CNY
4/29/20268.17 CNY
4/28/20268.00 CNY
4/27/20268.01 CNY
4/24/20267.98 CNY
4/23/20268.13 CNY
4/22/20268.38 CNY
4/21/20267.70 CNY
4/20/20267.72 CNY
4/17/20267.64 CNY
4/16/20267.78 CNY
4/15/20267.70 CNY
4/14/20267.65 CNY
4/13/20267.75 CNY
4/10/20267.71 CNY
4/9/20267.59 CNY
4/8/20267.98 CNY
4/7/20267.67 CNY
4/3/20267.42 CNY
4/2/20267.84 CNY
4/1/20267.89 CNY
3/31/20267.67 CNY
3/30/20267.80 CNY
3/27/20267.70 CNY
3/26/20267.41 CNY
3/25/20267.63 CNY
3/24/20267.45 CNY
3/23/20267.06 CNY
3/20/20267.66 CNY
3/19/20268.28 CNY
3/18/20268.50 CNY
3/17/20268.22 CNY
3/16/20268.45 CNY
3/13/20268.40 CNY
3/12/20268.37 CNY
3/11/20268.47 CNY
3/10/20268.60 CNY
3/9/20268.37 CNY
3/6/20268.47 CNY
3/5/20268.14 CNY
2/26/20268.36 CNY
2/25/20268.41 CNY
2/24/20268.48 CNY
2/13/20268.33 CNY
2/12/20268.20 CNY
2/11/20268.28 CNY
2/10/20268.40 CNY
2/9/20268.40 CNY
2/6/20268.24 CNY
2/5/20268.23 CNY
2/4/20268.24 CNY
2/3/20268.18 CNY
2/2/20268.09 CNY
1/30/20268.10 CNY
1/29/20268.09 CNY
1/28/20268.11 CNY
1/27/20268.38 CNY
1/26/20268.40 CNY
1/23/20268.35 CNY
1/22/20268.19 CNY
1/21/20268.19 CNY
1/20/20268.13 CNY
1/19/20268.11 CNY
1/16/20268.04 CNY
1/15/20268.15 CNY
1/14/20268.35 CNY
1/13/20268.39 CNY
1/12/20268.18 CNY
1/9/20268.03 CNY
1/8/20267.89 CNY
1/7/20267.62 CNY
1/6/20267.88 CNY
1/5/20267.91 CNY
12/31/20257.36 CNY
12/30/20257.32 CNY
12/29/20257.40 CNY
12/26/20257.40 CNY
12/25/20257.52 CNY
12/24/20257.44 CNY
12/23/20257.44 CNY
12/22/20257.53 CNY
12/19/20257.61 CNY
12/18/20257.40 CNY
12/17/20257.23 CNY
12/16/20257.26 CNY
12/15/20257.34 CNY
12/12/20257.26 CNY
12/11/20257.38 CNY
12/10/20257.65 CNY
12/9/20257.74 CNY
12/8/20257.87 CNY
12/5/20257.87 CNY
12/4/20257.83 CNY
12/3/20257.94 CNY
12/2/20258.04 CNY
12/1/20258.07 CNY
11/28/20258.13 CNY
11/27/20258.13 CNY
11/26/20257.97 CNY
11/25/20257.99 CNY
11/24/20257.90 CNY
11/21/20257.65 CNY
11/20/20258.02 CNY
11/19/20258.06 CNY
11/18/20258.23 CNY
11/17/20258.30 CNY
11/14/20258.36 CNY
11/13/20258.38 CNY
11/12/20258.58 CNY
11/11/20258.24 CNY
11/10/20258.20 CNY
11/7/20258.13 CNY
11/6/20258.17 CNY
11/5/20258.19 CNY
11/4/20258.12 CNY
11/3/20258.14 CNY
10/31/20258.10 CNY
10/30/20257.89 CNY
10/29/20257.99 CNY
10/28/20258.10 CNY
10/27/20257.98 CNY
10/24/20257.97 CNY
10/23/20257.92 CNY
10/22/20257.89 CNY
10/21/20257.87 CNY
10/20/20257.69 CNY
10/17/20257.52 CNY
10/16/20257.60 CNY
10/15/20257.67 CNY
10/14/20257.63 CNY
10/13/20257.59 CNY
10/10/20257.57 CNY
10/9/20257.54 CNY
9/30/20257.67 CNY
9/29/20257.67 CNY
9/26/20257.60 CNY
9/25/20257.64 CNY
9/24/20257.72 CNY
9/23/20257.62 CNY
9/22/20257.76 CNY
9/19/20257.87 CNY
9/18/20257.92 CNY
9/17/20258.17 CNY
9/16/20258.14 CNY
9/15/20257.99 CNY
9/12/20258.10 CNY
9/11/20258.17 CNY
9/10/20258.02 CNY
9/9/20258.09 CNY
9/8/20258.28 CNY
9/5/20258.05 CNY
9/4/20258.02 CNY
9/3/20257.78 CNY
9/2/20258.06 CNY
9/1/20258.18 CNY
8/29/20258.04 CNY
8/28/20258.19 CNY
8/27/20258.21 CNY
8/26/20258.71 CNY
8/25/20258.82 CNY
8/22/20258.65 CNY
8/21/20258.73 CNY
8/20/20258.81 CNY
8/19/20258.99 CNY
8/18/20259.07 CNY
8/15/20258.59 CNY
8/14/20258.35 CNY
8/13/20258.87 CNY
8/12/20259.13 CNY
8/11/20258.96 CNY
8/7/20259.29 CNY
8/6/20258.56 CNY
8/5/20258.87 CNY
8/4/20258.97 CNY
8/1/20258.58 CNY
7/31/20258.52 CNY
7/30/20258.17 CNY
7/29/20258.07 CNY
7/28/20258.14 CNY
7/25/20258.20 CNY
7/24/20257.93 CNY
7/23/20257.85 CNY
7/22/20257.89 CNY
7/21/20258.08 CNY
Access this data via the Eulerpool API
Get Free API Key

Improve Medical Instruments Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
549.70 M CNY
55.00 M CNY
11.20 M CNY
Jan 1, 2018
550.00 M CNY
-6.80 M CNY
-136.80 M CNY
Jan 1, 2019
575.10 M CNY
43.60 M CNY
26.00 M CNY
Jan 1, 2020
919.20 M CNY
115.00 M CNY
162.50 M CNY
Jan 1, 2021
799.83 M CNY
40.29 M CNY
18.57 M CNY
Jan 1, 2022
710.77 M CNY
-55.57 M CNY
-198.30 M CNY
Jan 1, 2023
644.62 M CNY
-30.71 M CNY
-63.20 M CNY
Jan 1, 2024
581.33 M CNY
-26.81 M CNY
-117.90 M CNY

Improve Medical Instruments Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 19, 2026, 8:49 PM
 
REVENUEM CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
140.00165.00249.00304.00396.00461.00545.00517.00549.00550.00575.00919.00799.00710.00644.00581.00
35.9217.8650.9122.0930.2616.4118.22-5.146.190.184.5559.83-13.06-11.14-9.30-9.78
46.4344.2444.1843.4241.9243.3843.3046.4244.6338.9144.5245.7038.6733.2436.1836.49
65.0073.00110.00132.00166.00200.00236.00240.00245.00214.00256.00420.00309.00236.00233.00212.00
29.0022.0032.0029.0040.0048.0041.0037.0055.00-6.0043.00115.0040.00-55.00-30.00-26.00
20.7113.3312.859.5410.1010.417.527.1610.02-1.097.4812.515.01-7.75-4.66-4.48
26.0029.0033.0037.0046.0053.0039.0030.0011.00-136.0026.00162.0018.00-198.00-63.00-117.00
30.0011.5413.7912.1224.3215.22-26.42-23.08-63.33-1,336.36-119.12523.08-88.89-1,200.00-68.1885.71
––0.050.060.060.050.060.05–0.03––0.030.04––
–––20.00–-16.6720.00-16.67–––––33.33––
212.80296.00296.00296.00296.00296.00308.80308.80308.80308.80308.80308.80309.48309.19309.19309.19
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Improve Medical Instruments Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Improve Medical Instruments Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Improve Medical Instruments Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Improve Medical Instruments Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Improve Medical Instruments Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Improve Medical Instruments Co stock margins

The Improve Medical Instruments Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Improve Medical Instruments Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Improve Medical Instruments Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
44.62 %
10.01 %
2.04 %
Jan 1, 2018
39.02 %
-1.24 %
-24.87 %
Jan 1, 2019
44.53 %
7.58 %
4.52 %
Jan 1, 2020
45.74 %
12.51 %
17.68 %
Jan 1, 2021
38.67 %
5.04 %
2.32 %
Jan 1, 2022
33.23 %
-7.82 %
-27.90 %
Jan 1, 2023
36.26 %
-4.76 %
-9.80 %
Jan 1, 2024
36.61 %
-4.61 %
-20.28 %

Improve Medical Instruments Co Stock Revenue, EBIT, Earnings per Share

The Improve Medical Instruments Co earnings per share therefore indicates how much revenue Improve Medical Instruments Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
1.78 CNY
0.18 CNY
0.04 CNY
Jan 1, 2018
1.78 CNY
-0.02 CNY
-0.44 CNY
Jan 1, 2019
1.86 CNY
0.14 CNY
0.08 CNY
Jan 1, 2020
2.98 CNY
0.37 CNY
0.53 CNY
Jan 1, 2021
2.58 CNY
0.13 CNY
0.06 CNY
Jan 1, 2022
2.30 CNY
-0.18 CNY
-0.64 CNY
Jan 1, 2023
2.08 CNY
-0.10 CNY
-0.20 CNY
Jan 1, 2024
1.88 CNY
-0.09 CNY
-0.38 CNY

Improve Medical Instruments Co business model & stock analysis

Improve Medical Instruments Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Improve Medical Instruments Co historical P/E ratio, EBIT multiple, and P/S ratio

Improve Medical Instruments Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Improve Medical Instruments Co shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
308.80 M Stocks
Jan 1, 2018
308.80 M Stocks
Jan 1, 2019
308.80 M Stocks
Jan 1, 2020
308.80 M Stocks
Jan 1, 2021
309.48 M Stocks
Jan 1, 2022
309.19 M Stocks
Jan 1, 2023
309.19 M Stocks
Jan 1, 2024
309.19 M Stocks

Improve Medical Instruments Co stock splits

In Improve Medical Instruments Co's history, there have been no stock splits.

Improve Medical Instruments Co Dividend History

9 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20220.04CNY↑ 25.0%1×
20210.03CNY↑ 28.0%1×
20180.03CNY 0.0%1×
20160.03CNY↓ 16.7%1×
20150.03CNY↑ 20.0%1×
20140.03CNY↓ 58.3%1×
20130.06CNY 0.0%1×
20120.06CNY↑ 20.0%1×
20110.05CNY—1×

Improve Medical Instruments Co dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
33.80 %
Jan 1, 2018
-5.68 %
Jan 1, 2019
37.38 %
Jan 1, 2020
41.51 %
Jan 1, 2021
53.33 %
Jan 1, 2022
-6.24 %
Jan 1, 2023
44.07 %
Jan 1, 2024
46.30 %
Price targets and forecasts for Improve Medical Instruments Co are not yet available.

Improve Medical Instruments Co shareholder structure

% Name
15.91078%
Deng (Guanhua)
Deng (Guanhua)
10.84394%
Zhuhai Gree Financial Investment Management Co., Ltd.
Zhuhai Gree Financial Investment Management Co., Ltd.
4.94841%
Zhao (Jiqing)
Zhao (Jiqing)
2.71484%
Yu (Wei Ping)
Yu (Wei Ping)
1.14674%
Fu (Weiming)
Fu (Weiming)
0.62130%
China Asset Management Co., Ltd.
China Asset Management Co., Ltd.

Improve Medical Instruments Co Executives and Management Board

HY

Ms. Hongyu Yan

Finance Director, Deputy General Manager · since 2017

Compensation290,300.00 CNY
GJ

Mr. Guangcheng Jiang

(56)

Acting General Manager, Deputy General Manager, Director · since 2024

Compensation280,000.00 CNY
TY

Mr. Tao Yang

(40)

Chairman of the Board · since 2024

GW

Ms. Geqi Wei

(50)

Deputy General Manager, Director

KT

Mr. Ke Tian

(50)

Deputy General Manager · since 2023

Frequently asked questions about Improve Medical Instruments Co

5 analysts currently rate the Improve Medical Instruments Co stock: 4 recommend buying, 1 holding and 0 selling.

Improve Medical Instruments Co Analyst Price Targets 2026

All fundamentals and in-depth analysis of Improve Medical Instruments Co

Our stock analysis for Improve Medical Instruments Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Improve Medical Instruments Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Improve Medical Instruments Co Stock
Improve Medical Instruments Co Revenue→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Net Income→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co P/E→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co P/S→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co EBIT→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Dividend→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Directors Dealings→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Stocks→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Market capitalization→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Debt→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Liabilities→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Equity→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co AAQS→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Employees→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co ROE→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co ROA→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co ROCE→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co News→
Improve Medical Instruments Co Stock
Improve Medical Instruments Co Analyst Price Targets→

Health Stocks

ImugeneImplanetImunonImpediMedIMVImmutep Ltd ADRIN8bioImmutepInBody CoImmuron Ltd ADRIncannex HealthcareImmuronAll Stocks A–Z →